This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Micromet Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations by Bernd Schlereth: Pioneering Bispecific Antibodies
Introduction
Bernd Schlereth, an innovative inventor based in Germering, Germany, has made significant contributions to the field of biomedicine. His expertise and dedication have led to the development of a unique patent, focusing on the utilization of bispecific antibodies with cross-species specificity.
Latest Patents
Schlereth holds a notable patent titled "Composition comprising cross-species-specific antibodies and uses thereof." This inventive work involves the use of bispecific antibodies to evaluate the in vivo safety, activity, and pharmacokinetic profile in both non-human species and humans. The invention encompasses methods for measuring the biological activity and efficacy of such antibodies, as well as the preparation of pharmaceutical compositions designed for treating various diseases.
Career Highlights
Bernd Schlereth is associated with Micromet AG, a company recognized for its innovative approaches in cancer treatment. His work at Micromet AG has placed him at the forefront of antibody research, showcasing his ability to bridge the gap between scientific innovation and practical application. His singular patent reflects his commitment to advancing therapeutic methodologies.
Collaborations
In his professional journey, Schlereth collaborates with talented colleagues such as Roman Kischel and Tobias Raum. Together, they contribute to a collaborative environment that fosters innovation and the development of novel biopharmaceutical products.
Conclusion
Bernd Schlereth's contributions through his patent on bispecific antibodies highlight the critical intersection of science and health. His work at Micromet AG and his collaborations with esteemed colleagues underscore the importance of teamwork in driving forward the boundaries of medical innovation. As research in this field progresses, Schlereth's inventions stand as a testament to the value of inventive thinking in addressing complex challenges in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile